Delayed
Japan Exchange
11:51:02 2024-06-10 pm EDT
|
5-day change
|
1st Jan Change
|
2,826
JPY
|
-0.46%
|
|
+1.15%
|
-5.80%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
136,736
|
123,844
|
155,452
|
124,107
|
120,926
|
110,676
|
-
|
-
|
Enterprise Value (EV)
1 |
88,283
|
76,055
|
95,227
|
35,311
|
38,555
|
44,556
|
54,280
|
58,074
|
P/E ratio
|
20.6
x
|
19.2
x
|
11.3
x
|
3.71
x
|
7.79
x
|
18.8
x
|
17.3
x
|
17.6
x
|
Yield
|
1.18%
|
1.55%
|
1.83%
|
3.88%
|
3.24%
|
2.75%
|
3.29%
|
3.29%
|
Capitalization / Revenue
|
1.17
x
|
1.03
x
|
1.12
x
|
0.67
x
|
0.76
x
|
0.82
x
|
0.78
x
|
0.76
x
|
EV / Revenue
|
0.75
x
|
0.63
x
|
0.69
x
|
0.19
x
|
0.24
x
|
0.32
x
|
0.38
x
|
0.4
x
|
EV / EBITDA
|
5.59
x
|
5.14
x
|
3.76
x
|
0.65
x
|
1.28
x
|
2.81
x
|
3.3
x
|
3.29
x
|
EV / FCF
|
8.91
x
|
10.1
x
|
6.35
x
|
0.92
x
|
9.37
x
|
-6.66
x
|
-18.3
x
|
13.6
x
|
FCF Yield
|
11.2%
|
9.94%
|
15.7%
|
108%
|
10.7%
|
-15%
|
-5.47%
|
7.37%
|
Price to Book
|
1.77
x
|
1.55
x
|
1.76
x
|
1.06
x
|
0.98
x
|
0.9
x
|
0.86
x
|
0.84
x
|
Nbr of stocks (in thousands)
|
42,597
|
42,617
|
40,641
|
40,164
|
39,198
|
38,984
|
-
|
-
|
Reference price
2 |
3,210
|
2,906
|
3,825
|
3,090
|
3,085
|
2,839
|
2,839
|
2,839
|
Announcement Date
|
5/10/19
|
5/13/20
|
5/13/21
|
5/13/22
|
5/12/23
|
5/10/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
117,129
|
120,732
|
138,571
|
186,067
|
159,462
|
137,964
|
141,100
|
145,300
|
EBITDA
1 |
15,782
|
14,806
|
25,301
|
54,690
|
30,193
|
15,867
|
16,450
|
17,650
|
EBIT
1 |
10,450
|
9,763
|
19,936
|
48,889
|
23,936
|
9,167
|
9,433
|
9,067
|
Operating Margin
|
8.92%
|
8.09%
|
14.39%
|
26.27%
|
15.01%
|
6.64%
|
6.69%
|
6.24%
|
Earnings before Tax (EBT)
1 |
10,844
|
10,175
|
21,002
|
50,328
|
24,184
|
9,523
|
10,050
|
9,750
|
Net income
1 |
6,646
|
6,375
|
13,711
|
33,741
|
15,578
|
6,034
|
6,133
|
5,933
|
Net margin
|
5.67%
|
5.28%
|
9.89%
|
18.13%
|
9.77%
|
4.37%
|
4.35%
|
4.08%
|
EPS
2 |
156.1
|
151.3
|
337.4
|
833.2
|
395.8
|
154.8
|
164.4
|
161.7
|
Free Cash Flow
1 |
9,904
|
7,558
|
14,990
|
38,306
|
4,115
|
-6,691
|
-2,970
|
4,280
|
FCF margin
|
8.46%
|
6.26%
|
10.82%
|
20.59%
|
2.58%
|
-4.85%
|
-2.11%
|
2.95%
|
FCF Conversion (EBITDA)
|
62.76%
|
51.05%
|
59.25%
|
70.04%
|
13.63%
|
-
|
-
|
24.25%
|
FCF Conversion (Net income)
|
149.02%
|
118.56%
|
109.33%
|
113.53%
|
26.42%
|
-
|
-
|
72.13%
|
Dividend per Share
2 |
38.00
|
45.00
|
70.00
|
120.0
|
100.0
|
80.00
|
93.33
|
93.33
|
Announcement Date
|
5/10/19
|
5/13/20
|
5/13/21
|
5/13/22
|
5/12/23
|
5/10/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
61,908
|
59,828
|
48,608
|
95,700
|
41,010
|
49,357
|
40,478
|
43,234
|
83,712
|
40,223
|
35,527
|
35,272
|
34,837
|
70,109
|
35,106
|
32,749
|
35,790
|
36,100
|
71,680
|
36,310
|
33,550
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
8,303
|
10,079
|
-
|
6,581
|
5,224
|
4,255
|
4,060
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
6,197
|
4,973
|
13,473
|
27,525
|
7,992
|
13,372
|
6,852
|
8,596
|
15,448
|
4,982
|
3,506
|
2,667
|
2,456
|
5,123
|
2,614
|
1,430
|
2,875
|
2,825
|
5,600
|
2,775
|
1,025
|
Operating Margin
|
10.01%
|
8.31%
|
27.72%
|
28.76%
|
19.49%
|
27.09%
|
16.93%
|
19.88%
|
18.45%
|
12.39%
|
9.87%
|
7.56%
|
7.05%
|
7.31%
|
7.45%
|
4.37%
|
8.03%
|
7.83%
|
7.81%
|
7.64%
|
3.06%
|
Earnings before Tax (EBT)
|
6,402
|
5,498
|
-
|
28,381
|
8,147
|
13,800
|
7,106
|
-
|
15,774
|
4,995
|
3,415
|
2,755
|
-
|
5,216
|
2,819
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
4,071
|
3,514
|
8,824
|
18,761
|
5,293
|
9,687
|
4,722
|
5,610
|
10,332
|
3,009
|
2,237
|
1,796
|
1,559
|
3,355
|
1,855
|
824
|
1,961
|
1,898
|
3,717
|
1,930
|
562.5
|
Net margin
|
6.58%
|
5.87%
|
18.15%
|
19.6%
|
12.91%
|
19.63%
|
11.67%
|
12.98%
|
12.34%
|
7.48%
|
6.3%
|
5.09%
|
4.48%
|
4.79%
|
5.28%
|
2.52%
|
5.48%
|
5.26%
|
5.19%
|
5.31%
|
1.68%
|
EPS
|
95.58
|
86.52
|
-
|
461.5
|
130.8
|
-
|
119.2
|
-
|
261.8
|
76.71
|
-
|
46.10
|
-
|
86.08
|
47.58
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
20.00
|
20.00
|
-
|
35.00
|
-
|
-
|
-
|
-
|
40.00
|
-
|
-
|
-
|
-
|
40.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/8/19
|
11/10/20
|
11/11/21
|
11/11/21
|
2/9/22
|
5/13/22
|
8/10/22
|
11/11/22
|
11/11/22
|
2/10/23
|
5/12/23
|
8/10/23
|
11/10/23
|
11/10/23
|
2/9/24
|
5/10/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
48,453
|
47,789
|
60,225
|
88,796
|
82,371
|
68,849
|
56,396
|
52,602
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
9,904
|
7,558
|
14,990
|
38,306
|
4,115
|
-6,691
|
-2,971
|
4,280
|
ROE (net income / shareholders' equity)
|
8.9%
|
8.3%
|
16.7%
|
33%
|
13.1%
|
4.9%
|
4.93%
|
4.83%
|
ROA (Net income/ Total Assets)
|
9.65%
|
8.79%
|
16.3%
|
32.1%
|
13.9%
|
5.65%
|
5%
|
4.8%
|
Assets
1 |
68,848
|
72,498
|
84,181
|
105,157
|
112,137
|
106,776
|
122,667
|
123,611
|
Book Value Per Share
2 |
1,809
|
1,873
|
2,174
|
2,909
|
3,139
|
3,228
|
3,293
|
3,366
|
Cash Flow per Share
2 |
274.0
|
271.0
|
469.0
|
976.0
|
555.0
|
327.0
|
365.0
|
427.0
|
Capex
1 |
2,603
|
2,939
|
3,091
|
5,694
|
9,738
|
20,927
|
20,000
|
11,500
|
Capex / Sales
|
2.22%
|
2.43%
|
2.23%
|
3.06%
|
6.11%
|
15.17%
|
14.17%
|
7.91%
|
Announcement Date
|
5/10/19
|
5/13/20
|
5/13/21
|
5/13/22
|
5/12/23
|
5/10/24
|
-
|
-
|
Last Close Price
2,839
JPY Average target price
3,000
JPY Spread / Average Target +5.67% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.80% | 702M | | -22.97% | 7.9B | | +76.82% | 4.53B | | +8.85% | 2.78B | | -2.80% | 2.64B | | -50.41% | 1.99B | | -17.68% | 1.66B | | -20.23% | 1.49B | | +19.61% | 1.23B | | -45.78% | 1.1B |
Medical & Diagnostic Laboratories
|